Skip to main content

Dr Jaspal Singh

Dr Jaspal Singh is a consultant paediatric neurologist with a sub-specialty interest in epilepsy, stroke, and sleep.

MBBS, FRCPCH

Training and education

Dr Singh completed medical school training in Manipal, India

He trained in paediatrics in hospitals around the country including the west midlands, north-west and London. He completed his training in paediatric neurology at hospitals in Southampton and Birmingham.

Dr Singh completed a stroke fellowship at The Hospital for Sick children, Toronto, Canada, followed by an honorary fellowship in paediatric epilepsy and epilepsy surgery at Great Ormond Street Hospital, London.

Experience

Dr Singh has worked at the Trust since 2012 and as a consultant since 2015. He has experience treating complex epilepsy neurovascular diseases of childhood, stroke neurogenetics and general neurology.

Key achievements

  • Chair of British Paediatric Neurology Cerebrovascular Interest Group
  • Past Chair, GMSA Specialty specific genomics network (paediatric neurology)
  • Epilepsy education and lecturing both regionally and nationally, as part of the paediatric epilepsy training faculty
  • Contributing member of RESCAS and BPEG

Research

Dr Singh is principal investigator for the PASTA trial (paediatric arteriopathy steroid aspirin trial).

Recurrent stroke: the role of thrombophilia in a large international pediatric stroke population. Haematologica. 2019 Aug;104(8):1676-1681. doi: 10.3324/haematol.2018.211433. Epub 2019 Jan 24. Erratum in: Haematologica. 2019 Oct;104(10):2116. PMID: 30679327; PMCID: PMC6669164.

Obstructive sleep apnea syndrome and neuropsychological function in pediatric stroke. Eur J Paediatr Neurol. 2020 Mar;25:82-89. doi: 10.1016/j.ejpn.2019.11.006. Epub 2019 Nov 21. PMID: 31787553.

ADCY5-related dyskinesia presenting as familial myoclonus-dystonia. Neurogenetics. 2017 Apr;18(2):111-117. doi: 10.1007/s10048-017-0510-z. Epub 2017 Feb 22. PMID: 28229249; PMCID: PMC5359383.

Elevated pterins in cerebral spinal fluid--biochemical marker of Aicardi-Goutières syndrome. Dev Med Child Neurol. 2009 Oct;51(10):841-2. doi: 10.1111/j.1469-8749.2009.03379.x. Epub 2009 Aug 18. PMID: 19694776.

Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes. Cochrane Database of Systematic Reviews 2014, Issue 9. Art. No.: CD006779. DOI: 10.1002/14651858.CD006779.pub2. Accessed 26 March 2021.

COVID-19 symptom surveillance in immunocompromised children and young people in the UK: a prospective observational cohort study. BMJ Open 2021;11:e044899. doi:10.1136/ bmjopen-2020-044899

Contact

You can email Dr Singh's secretary, Jorelle Quillas by calling 023 8120 4457 or sending an email to paedsneurologyadmin@uhs.nhs.uk